| Non-survivors | Survivors | p-value |
---|---|---|---|
n = 34 | n = 31 | ||
ECMO modes | Â | Â | 0.018 |
VA mode | 31 | 21 | Â |
Change from VA to VV | - | 1 | Â |
Change from VA to V-AV | 1 | - | Â |
Change from VA to V-AV, and then to VV | - | 1 | Â |
V-AV mode | 2 | 1 | Â |
Change from V-AV to VV | 1 | - | Â |
VV mode | 1 | 9 | Â |
Anticoagulants | Â | Â | 0.179 |
Nafamostat mesilate | 30 | 26 | Â |
Heparin | 2 | 5 | Â |
ECMO run of ≤24 h | 9 | 1 | 0.014a |
Surgery after ECMO | - | 4 | 0.046a |
ECMO duration, h | 72.5 (23.8, 118) | 143.0 (93, 212) | 0.001 |
CRRT | 18 (60Â %) | 5 (71Â %) | 0.687a |
Daily blood transfusion, unit/d | - | - | Â |
Packed red blood cells | 1.9 (0.9, 3.0) | 1.0 (0.7, 1.3) | 0.002 |
Fresh frozen plasma | 1.0 (0.5, 2.4) | 0.3 (0.0, 0.7) | 0.001 |
Platelet concentrate | 1.7 (0.0, 5.0) | 1.3 (0.0, 3.3) | 0.823 |
Length of stay | Â | Â | Â |
ICU | 4 (2, 7) | 18 (11, 30) | <0.001 |
Hospital | 4 (2, 7) | 28 (20, 51) | <0.001 |